CHR Chr. Hansen Holding A/S

Lise Skaarup Mortensen appointed new CFO of Chr. Hansen Holding A/S

Lise Skaarup Mortensen appointed new CFO of Chr. Hansen Holding A/S

Company announcement No. 18 / 2020

July 9, 2020

Chr. Hansen Holding A/S has today appointed Lise Skaarup Mortensen as new Chief Financial Officer (CFO). Lise is an experienced international leader with a strong track-record and a passion for leadership who joins from a position as CFO at Microsoft Germany.

Lise Skaarup Mortensen (52) has a strong financial background with many years of experience in large international companies and has for the past eight years been with Microsoft in international senior managerial positions in India and Germany. Prior to joining Microsoft, Lise has held senior level positions within the fields of finance and strategy at IBM, AP Moller-Maersk and BG Bank.

Commenting on the appointment, CEO Mauricio Graber says: “I am very pleased that we have found in Lise the right CFO for Chr. Hansen. Lise has very relevant international experience, high performance aspirations and a great leadership track record. Coming from the software and digital services industry, Lise will be well-positioned to help Chr. Hansen and our teams further develop our digital, data analytics and productivity agenda. Lise is ambitious and purpose driven, which makes her a great cultural fit to the organization. Moreover, I feel confident that her vast international experience will enable her to bring even more diversity of thought to our corporate leadership team. I am looking forward to welcoming Lise to Chr. Hansen.”

“Chr. Hansen has a great reputation and I feel honored to join such a respected Danish company. Becoming part of a team that enables compelling business opportunities grounded in the relevance of natural ingredients in today’s world – and with strong focus on sustainability – is a privilege. I look forward to getting to know my new colleagues and contribute to the future growth journey of Chr. Hansen,” adds Lise Skaarup Mortensen.

Lise Skaarup Mortensen will start at Chr. Hansen on October 1, 2020, after which there will be a short transition period until current CFO Søren Westh Lonning leaves, expected by the end of October. Lise will join the Executive Board after the transition period is completed.

Lise Skaarup Mortensen is a Danish national, currently living in Munich. She will relocate back to Denmark to take up this position. Lise holds a master’s degree in Business Administration & Economics from the University of Aarhus, Denmark.

For further information please contact:

Martin Riise, Head of Investor Relations, Tel:

Annika Stern, Investor Relations Officer, Tel:

Camilla Lercke, Head of Media Relations, Tel:

About Chr. Hansen

Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on around 40,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. Sustainability is an integral part of Chr. Hansen’s vision to improve food and health. In 2019 Chr. Hansen was ranked as the world’s most sustainable company by Corporate Knights thanks to our strong sustainability efforts and our many collaborative partnerships with our customers. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day.

Attachment

EN
09/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chr. Hansen Holding A/S

Rune Majlund Dahl
  • Rune Majlund Dahl

Chr. Hansen (No_rec, TP: DKK) - Discontinuing coverage

We have discontinued coverage of Chr. Hansen in light of its combination with Novozymes. Our last published recommendation, target price, and estimates should no longer be relied upon.

 PRESS RELEASE

Completion of the combination between Novozymes and Chr. Hansen

Completion of the combination between Novozymes and Chr. Hansen January 29, 2024 – Company announcement no. 2 Please see attachment. CONTACT INFORMATION Investor Relations Tobias Cornelius Bjorklund Anders Enevoldsen Press Relations Lina Danstrup Attachment

 PRESS RELEASE

All necessary regulatory approvals have been obtained for the combinat...

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen January 26, 2024 – Company announcement no. 1 Please see attachment. Contact information Investor RelationsDisa Tuominen Press RelationsSanne Seyer-Hansen Attachment

Rune Majlund Dahl
  • Rune Majlund Dahl

Chr. Hansen (Hold, TP: DKK582.00) - Down to HOLD, target price raised

We forecast Chr. Hansen to reach the high end of its 2023 guidance of 10–12% organic revenue growth and a 26–27% EBIT margin, but expect the combined entity (Novonesis) to issue a new guidance upon completion of the merger. As Chr. Hansen shareholders are set to receive 1.5236 new B-shares in Novonesis, the changes in our Novozymes model translate into a raised Chr. Hansen target price of DKK582 (536), and we have thus downgraded to HOLD (BUY).

 PRESS RELEASE

Update on the merger approval process for the combination of Novozymes...

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted December 20, 2023 Please see attachment. Contact information Investor RelationsDisa Tuominen Press RelationsSanne Seyer-Hansen Attachment

ResearchPool Subscriptions

Get the most out of your insights

Get in touch